Datacubed Health Names Leaders in Neurology, Genomics, Internal Medicine, Rare Disease and Psychiatry to Science Advisor Panel

Company rebrands to focus on clinical research and science

BROOKLYN, N.Y.Feb. 11, 2019 /PRNewswire/ — Datacubed Health today announced the appointment of its new Science Advisor Panel, consisting of world-renowned scientists and technologists spanning a wide and diverse range of fields.

The Science Advisor Panel includes: a creator of the MIT Media Lab, a former leader of the U.S. Human Genome Project, a former director of the U.S. National Institute of Mental Health, the designer of top-selling video games, a former Chief of Medicine at Massachusetts General Hospital and a neurologist from a leading biotech company.

The Advisor Panel will help clients evaluate new virtual and remote study alternatives to traditional protocol design and advise Datacubed Health on the best practices for clinical outcome assessments, validation of scales and other processes.

“These senior advisors–all leading figures in their disciplines–will bring strength, guidance and oversight to clinical trial processes at Datacubed Health,” said Paul Glimcher, the company’s Chief Executive Officer. “With this level of expertise supporting us in fields as diverse as genomics, psychiatry, neurology and internal medicine, we will be able to identify and pursue a wide variety of novel and innovative approaches to clinical and scientific issues.”

Learn more about the Science Advisors: https://www.datacubed.com/scienceadvisors/

Alex “Sandy” Pentland – A pioneer in mobile data collection, Dr. Pentland directs the MIT Connection Science and Human Dynamics labs and previously helped create and direct the MIT Media Lab and the Media Lab Asia in India. Forbes recently described him as one of the “seven most powerful data scientists in the world.”

Aristides Patrinos – A leading authority on genomics, structural biology, global environmental changes and nuclear medicine, Dr. Patrinos is formerly a leader of the U.S. Human Genome Project and a senior official in the U.S. Department of Energy. He is currently Chief Scientist, Director of Research and Chair of the Science Advisory Board at Novim.

Steven E. Hyman – A neuroscientist and psychiatrist, Dr. Hyman is the director of the Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard University and Harvard Professor of Stem Cell and Regenerative Biology. A former provost of Harvard University, the institution’s chief academic officer, Dr. Hyman served as director of The National Institute of Mental Health from 1996 to 2001.

Nicholas Fortugno – An American game designer and educator, Mr. Fortugno is the Chief Creative Officer of Playmatics LLC, a New York City-based game development studio. He designed Diner Dash, a top-selling causal game developed by Gamelab, and the award-winning game Ayiti: The Cost of Life. Since 2002, he has taught the Game Design and Interactive Narrative program at Columbia and SVA (School of Visual Arts).

Dennis Ausiello – A nationally recognized leader in academic and internal medicine, Dr. Ausiello is the Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. He was formerly Chief of Medicine at Massachusetts General Hospital.

David H. Margolin – Dr. Margolin, a neurologist, is Senior Vice President of Clinical and Translational Medicine at Cerevance, Inc., a drug discovery and development company focused on brain diseases. He previously served in leadership roles at Sanofi-Genzyme where he designed and led translational medicine across various neurologic and rare disease indications. Dr. Margolin also served on the faculty in neurology at Harvard Medical School for 15 years.

At the same time as forming of the Science Advisor Panel, the company has undergone a rebranding, changing its name from Data Cubed to Datacubed Health. The rebrand is a strategic shift to align the company with its primary mission to support clinical research and studies across the pharmaceutical, biopharma, academic and healthcare landscape. Datacubed Health is strategically positioned to support virtual, remote and hybrid clinical trials via its unique technology platform, Linkt (formerly Sidekick), which operates on a patient’s own mobile device (BYOD) to enhance patient engagement and retention. Linkt is a modern end-to-end platform that links patients, caregivers, and clinicians with the leading patient engagement, econsent, and electronic outcomes assessments (eCOA) solution.

Learn more about the rebrand: https://www.datacubed.com/datacubedhealth/

About Datacubed Health
Datacubed Health is a pioneering technology company making better science and healthier communities a reality. We apply individualized solutions for the capture of data, including smartphone apps, wearable, in-home, and environmental sensors, for remote engagement with patients and for virtual clinical studies. Focusing on healthcare and life sciences, Datacubed Health offers software and services based on behavioral science to improve patient retention and compliance, resulting in better data and positive health outcomes. We believe that the best way to unlock the insights that have eluded scientists is understanding the holistic life of an individual.

Find out more about Datacubed Health by visiting datacubed.com. Datacubed Health is on LinkedIn and Twitter @DatacubedHealth.

SOURCE Datacubed Health